CELEX: 62009TA0131
Language: en
Date: 2010-10-28 00:00:00
Title: Case T-131/09: Judgment of the General Court of 28 October 2010 — Farmeco v OHIM — Allergan (BOTUMAX) (Community trade mark — Opposition proceedings — Application for the Community word mark BOTUMAX — Earlier Community word and figurative marks BOTOX — Relative grounds for refusal — Likelihood of confusion — Damage to reputation — Article 8(1)(b) and (5) of Regulation (EC) No 40/94 (now Article 8(1)(b) and (5) of Regulation (EC) No 207/2009))

18.12.2010   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 346/40
            
         Judgment of the General Court of 28 October 2010 — Farmeco v OHIM — Allergan (BOTUMAX)
   (Case T-131/09) (1)
   
   (Community trade mark - Opposition proceedings - Application for the Community word mark BOTUMAX - Earlier Community word and figurative marks BOTOX - Relative grounds for refusal - Likelihood of confusion - Damage to reputation - Article 8(1)(b) and (5) of Regulation (EC) No 40/94 (now Article 8(1)(b) and (5) of Regulation (EC) No 207/2009))
   2010/C 346/80
   Language of the case: English
   
      Parties
   
   
      Applicant: Farmeco AE Dermokallyntika (Athens, Greece) (represented by: N. Lymperis, lawyer)
   
      Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: A. Folliard-Monguiral, acting as Agent)
   
      Other party to the proceedings before the Board of Appeal of OHIM: Allergan Inc. (Irvine, California, United States)
   
      Re:
   
   Action brought against the decision of the Fourth Board of Appeal of OHIM of 2 February 2009 (Case R 60/2008-4), relating to opposition proceedings between Allergan Inc. and Farmeco AE Dermokallyntika.
   
      Operative part of the judgment
   
   The Court:
   
               1.
            
            
               Dismisses the action;
            
         
               2.
            
            
               Orders Farmeco AE Dermokallyntika to pay the costs.
            
         
      (1)  OJ C 129, 6.6.2009.